These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32643964)

  • 1. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
    DeSear KE; Thompson-Leduc P; Van Schooneveld TC; Kirson N; Chritton JJ; Ie S; Cheung HC; Ou S; Zimmer L; Schuetz P
    Curr Med Res Opin; 2021 May; 37(5):727-733. PubMed ID: 33617362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower Respiratory Tract Infections.
    Levine AR; Riggott R; Vulaj K; Falcetti TR; Ali S; Singh G
    Ann Pharmacother; 2018 Jun; 52(6):538-545. PubMed ID: 29322872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.
    Voermans AM; Mewes JC; Broyles MR; Steuten LMG
    OMICS; 2019 Oct; 23(10):508-515. PubMed ID: 31509068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Procalcitonin as a Sepsis Marker in a Community Hospital.
    De Oro N; Gauthreaux ME; Lamoureux J; Scott J
    J Appl Lab Med; 2019 Jan; 3(4):545-552. PubMed ID: 31639723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.
    Gluck E; Nguyen HB; Yalamanchili K; McCusker M; Madala J; Corvino FA; Zhu X; Balk R
    PLoS One; 2018; 13(10):e0205924. PubMed ID: 30332466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
    Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
    Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis.
    Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z
    Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
    Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
    Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin: Where Are We Now?
    Hamade B; Huang DT
    Crit Care Clin; 2020 Jan; 36(1):23-40. PubMed ID: 31733680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
    Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
    J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.